| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |